Showing results (381-390 of 452) with videos related to
Sort By:
Pageof 46
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2024
Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trialMaria A Rocca, Paola Valsasina, Francesco Romanò, et al.Journal of the Neurological Sciences|July 4, 2024
Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosisValerio Nicolella, Mariano Fiorenza, Isabel Monteiro, et al.European Journal of Neurology|May 8, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?Irene Schiavetti, Matilde Inglese, Jessica Frau, et al.Journal of Clinical Medicine|December 19, 2020
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the IcebergNicola Capasso, Raffaele Palladino, Emma Montella, et al.Neuroradiology|January 9, 2019
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple SclerosisSirio Cocozza, Giuseppe Pontillo, Roberta Lanzillo, et al.Neurology International|September 26, 2025
Plasma Neurofilament Light Chain Is Associated with Cognitive Functions but Not Patient-Reported Outcomes in Multiple SclerosisValerio Nicolella, Federica Novarella, Fabrizia Falco, et al.Brain : a Journal of Neurology|June 5, 2014
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergeticsOscar G Vidaurre, Jeffery D Haines, Ilana Katz Sand, et al.Plos One|March 7, 2014
Radiologically isolated syndrome: 5-year risk for an initial clinical eventDarin T Okuda, Aksel Siva, Orhun Kantarci, et al.Annals of Clinical and Translational Neurology|January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophyErmelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.Metabolism: Clinical and Experimental|May 20, 2015
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetatePietro B Carrieri, Fortunata Carbone, Francesco Perna, et al.Pageof 46